According to The Insight Partners' research, the Asia Pacific Companion Animal Diagnostics Market was valued at US$ 840.0 Million in 2024 and is expected to reach US$ 1,653.5 Million by 2031, registering a CAGR of 10.2% from 2025 to 2031.
Rising Number of Strategic Initiatives and Growing Pet Humanization and Ownership are among the critical factors attributed to the Asia Pacific companion animal diagnostics market expansion.
Small and big companies operating in the companion animal diagnostics market are increasingly adopting strategies such as geographic expansion, product development, and technological advancements to boost their revenues. A few recent developments in the companion animal diagnostics market are mentioned below:
· The growing number of strategic initiatives in India is significantly boosting the companion animal diagnostics market. For example, in March 2023, the Indian Institute of Information Technology, Allahabad (IIIT-A) announced the development of an AI-based system to detect Foot and Mouth Disease (FMD) in cattle at an early stage, using thermal imaging and deep learning neural networks. This initiative is backed by the Uttar Pradesh Council of Science and Technology (UPCST) and supports the state's "Smart Village" and "Digital Empowerment" programs. These programs aim to improve rural economic stability and livestock health management.
Therefore, the active participation of market players in product launches, expansions, partnerships, and mergers & acquisitions is expected to create lucrative growth opportunities in the companion animal diagnostics market in the coming years.
On the contrary, the high cost of diagnostic products and infrastructure hampers the growth of the Asia Pacific companion animal diagnostics market.
Asia Pacific Companion Animal Diagnostics Market Segmentation Analysis:
- By Product, the Asia Pacific Companion Animal Diagnostics Market is segmented into Consumables and Instruments. The Consumables segment is projected to expand at 10.5% CAGR during 2025 - 2031.
- By Companion Animal, the Asia Pacific Companion Animal Diagnostics Market is segmented into Dogs, Cats, Horses, and Others. The Dogs segment is projected to expand at 10.7% CAGR during 2025 - 2031.
- By Technology, the Asia Pacific Companion Animal Diagnostics Market is segmented into Immunodiagnostics, Molecular Diagnostics, Clinical Biochemistry, Hematology, Urinalysis, and Others. The Immunodiagnostics segment is projected to expand at 11.0% CAGR during 2025 - 2031.
- By Application, the Asia Pacific Companion Animal Diagnostics Market is segmented into Clinical Pathology, Bacteriology, Parasitology, Virology, and Others. The Clinical Pathology segment is projected to expand at 10.8% CAGR during 2025 - 2031.
- By End Users, the Asia Pacific Companion Animal Diagnostics Market is segmented into Diagnostic and Reference Laboratories, Veterinary Hospitals and Clinics, Research Institutes, and Others. The Veterinary Hospitals and Clinics segment is projected to expand at 10.4% CAGR during 2025 - 2031.
By country, the Asia Pacific Companion Animal Diagnostics Market is categorized into China, India, Japan, Australia, South Korea, and the Rest of APAC. China is projected to expand at 10.7% CAGR during 2025 - 2031.
Key players operating in the Companion Animal Diagnostics Market are Zoetis Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Tianjin LOCMEDT Technologies Co Ltd, ARI Medical Technology Co Ltd, and Demeditec Diagnostics GmbH, among others.
- In June 2025, IDEXX Laboratories, Inc. launched the Catalyst Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and diagnosis and management of Cushing's syndrome in dogs. IDEXX's Catalyst Cortisol Test is the third menu expansion in under a year for the Catalyst platform, further advancing the diagnostic capabilities available to veterinary practices at the point-of-care.
- In January 2024, IDEXX Laboratories, Inc. announced the launch of the IDEXX inVue Dx Cellular Analyzer, a first-of-its-kind slide-free cellular analyzer to detect the most common cytologic changes found in ear and blood samples. With deep AI learning models trained by IDEXX board-certified pathologists, the in-clinic analyzer provides practitioners with reference-laboratory quality results in 10 minutes. Unlike traditional slide methods, the IDEXX inVue Dx analyzer examines cells in their natural state, providing multidimensional images of sample findings and enabling diagnostic insights like never before.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com